Sdas

We are a leading generic pharmaceutical company with a significant presence in the Middle East, North Africa (MENA) region and the United States and Europe.

Currently, we sell 176 pharmaceutical products in 397 dosage strengths and forms in 40 countries. 28 of our products are sold under promotion and distribution agreements with, or licenses from, 16 originator pharmaceutical companies and three generic pharmaceutical companies.

Also; we do have a dedicated APIs FDA approved facility capable of manufacturing the following APIs:

API Name US DMF Status
Betamethasone Acetate, USP FDA Approved
Triamcinolone Acetonide, USP In Progress
Triamcinolone Hexacetonide, USP In Progress
Methyl Prednisolone Acetate, USP In Progress
P ...rednisone Anhydrous, USP Submitted
Cortisone Acetate, USP FDA Approved
Hydrocortisone, USP Submitted
Oxandrolone, USP In Progress
Prednisolone, USP Submitted
Finasteride, USP Upon request
Diflorasone Upon request
Granisetron Hydrochloride (Inj/Oral) In Progress
Ondansetron Hydrochloride, USP (Inj/Oral) In Progress
Glycopyrrolate, USP (Inj/Oral) Submitted
Zoledronic Acid (Inj) In Progress
Milrinone, USP (Inj) Upon request
Pamidronic Acid (Inj) Upon request
Nicardipine Hydrochloride (Inj/Oral) In Progress
Indomethacin Sodium (Inj) In Progress
Prifinium Bromide (Inj/Oral) Upon request
Enalaprilat, USP (Inj) Submitted
Warfarin Sodium, USP (Inj/Oral) In Progress
Fenoldopam (Inj) Upon request
Residronate (Inj) Upon request
Anagrelide Hydrochloride (Oral) In Progress Read more